A Systematic Review and Meta-Analysis of the Effectiveness of Adherence Therapy and Its Treatment Duration in Patients with Schizophrenia Spectrum Disorders

DOI: https://doi.org/10.2147/PPA.S401650

2023-03-22

Patient Preference and Adherence

Abstract:I Hsien Li, Wen Ling Hsieh, Wen I Liu School of Nursing, National Taipei University of Nursing and Health Sciences, Taipei City, Taiwan Correspondence: Wen I Liu, School of Nursing, National Taipei University of Nursing and Health Sciences, 365, Ming Te Road, Peitou, Taipei City, 112303, Taiwan, Tel +886-2-28227101 Ext 3184, Fax +886-2-28280219, Email Background: Adherence therapy (AT) is an intervention for improving medication adherence of people with schizophrenia spectrum disorders, but no systematic reviews have yet summarized the effectiveness and minimum treatment duration of AT. We here aimed to systematically examine the effectiveness of AT in improving outcomes versus treatment as usual (TAU) and its minimum effective duration for people diagnosed with schizophrenia spectrum disorders. Patients and Methods: Eligible randomized controlled trials were identified from four databases (Web of Science, PubMed, CINAHL and Cochrane Library) for the period 1 January 2006 to 1 January 2023. Of 1087 retrieved candidate studies, five studies with a total of 726 participants met the inclusion criteria. The search terms consisted of adherence therapy, compliance therapy, schizophrenia, schizoaffective disorder, schizophrenic disorder, medication adherence, and medication compliance (combined with OR and AND). Two investigators independently selected studies, extracted data, and conducted bias risk assessments. Random-effects models were used to analyze the pooled data. Results: Meta-analysis of the five selected studies showed that AT had a significantly greater positive effects than TAU on psychiatric symptoms, but no significant effects on adherence behaviors and attitudes. Conclusion: The AT had limited effects in terms of improving the attitudes and behaviors of people with schizophrenia spectrum disorders with respect to medication adherence, but did improve patients' psychiatric symptoms. The therapy should be performed by trained staff for maximum benefit, and the recommended duration of the intervention is 12 hours. Keywords: adherence therapy, medication adherence, psychiatric symptoms, motivational interviewing Schizophrenia spectrum disorders are chronic psychiatric disorders that require medical treatment. After the medication is discontinued, patients may also experience recurrent episodes of the disease. Recurrence rates after the discontinuation of antipsychotic medications have been reported to be as high as 77% to >90%, 1,2 largely because of medication nonadherence. 3,4 Previous studies have reported that 54.5–80% of patients failed to take their medications regularly, 5–7 leading to recurrent episodes of psychiatric symptoms and rehospitalization and a consequent increase in the burdens on healthcare professionals and finances. 8,9 Studies have shown, however, that the administration of long-acting injectable antipsychotics can stabilize patients and reduce relapses. 10 Making use of community-based care then allows them to return from the hospital to the community. The key factor in this step is that they must adhere to their medications to avoid relapses. However, many challenges have been reported in promoting medication adherence among community-dwelling patients. 11 From the recovery perspective, it is best if these individuals take their medication voluntarily after they return to the community. Assisting them in taking their medication consistently and regularly to control their symptoms is thus one of the essential functions of mental health care professionals and a critical direction of current mental health policy. 12 In clinical practice, patients are generally taught about diseases and medications and then simply expected to adhere to their medication regime. Past research has, however, demonstrated that while health education increases patient knowledge of their disease and treatment, it does not improve medication adherence. 13 The reasons for medication nonadherence are complex and can include the lack of a support system, lack of interpersonal relationships with healthcare professionals, and poor insight, coupled with substance abuse behaviors, negative attitudes toward medications, presence of side effects, and cognitive impairment. 9,14,15 Many ways to improve medication adherence have been explored. A recent study suggested that an effective strategy to improve medication adherence in psychiatric patients is to merge behavioral and educational approaches. 16 This study mainly focused on intervention in the form of adherence therapy (AT). Adherence therapy, developed by Gray et al in 2006, is a short-term intervention based on cognitive behavioral therapy (CBT) and motivational interview -Abstract Truncated-

medicine, general & internal